Bullous pemphigoid: An immune disorder related to aging (Review)
- Authors:
- Maria Ludovica Deotto
- Alice Spiller
- Alvise Sernicola
- Mauro Alaibac
-
Affiliations: Dermatology Unit, Department of Medicine, University of Padova, I-35121 Padua, Italy - Published online on: November 15, 2021 https://doi.org/10.3892/etm.2021.10972
- Article Number: 50
This article is mentioned in:
Abstract
 |
|
Parker SR and MacKelfresh J: Autoimmune blistering diseases in the elderly. Clin Dermatol. 29:69–79. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Bernard P and Antonicelli F: Bullous pemphigoid: A review of its Diagnosis, Associations and Treatment. Am J Clin Dermatol. 18:513–528. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Miyamoto D, Santi CG, Aoki V and Maruta CW: Bullous pemphigoid. An Bras Dermatol. 94:133–146. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Patel F, Wilken R, Patel FB, Sultani H, Bustos I, Duong C, Zone JJ, Raychaudhuri SP and Maverakis E: Pathophysiology of autoimmune bullous diseases: Nature versus nurture. Indian J Dermatol. 62:262–267. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Yang M, Wu H, Zhao M, Chang C and Lu Q: The pathogenesis of bullous skin diseases. J Transl Autoimmun. 2(100014)2019.PubMed/NCBI View Article : Google Scholar | |
|
Marazza G, Pham HC, Schärer L, Pedrazzetti PP, Hunziker T, Trüeb RM, Hohl D, Itin P, Lautenschlager S, Naldi L, et al: Incidence of bullous pemphigoid and pemphigus in Switzerland: A 2-year prospective study. Br J Dermatol. 161:861–868. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Langan SM, Smeeth L, Hubbard R, Fleming KM, Smith CJ and West J: Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: Population based cohort study. BMJ. 337(a180)2008.PubMed/NCBI View Article : Google Scholar | |
|
Gudi VS, White MI, Cruickshank N, Herriot R, Edwards SL, Nimmo F and Ormerod AD: Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland. Br J Dermatol. 153:424–427. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Hübner F, Recke A, Zillikens D, Linder R and Schmidt E: Prevalence and age distribution of pemphigus and pemphigoid diseases in Germany. J Invest Dermatol. 136:2495–2498. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Feliciani C, Caldarola G, Kneisel A, Podstawa E, Pfütze M, Pfützner W and Hertl M: IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Br J Dermatol. 161:306–312. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Hopkinson SB and Jones JC: The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome. Mol Biol Cell. 11:277–286. 2000.PubMed/NCBI View Article : Google Scholar | |
|
Giang J, Seelen MAJ, van Doorn MBA, Rissmann R, Prens EP and Damman J: Complement activation in inflammatory skin diseases. Front Immunol. 9(639)2018.PubMed/NCBI View Article : Google Scholar | |
|
Fania L, Caldarola G, Müller R, Brandt O, Pellicano R, Feliciani C and Hertl M: IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses. Clin Immunol. 143:236–245. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, et al: Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid. Clin Immunol. 128:415–426. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Park SH, Lee SH, Kim JH and Kim SC: Circulating eosinophil and neutrophil counts correlate with disease severity in bullous pemphigoid. Ann Dermatol. 30:544–549. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Budamagunta V, Foster TC and Zhou D: Cellular senescence in lymphoid organs and immunosenescence. Aging (Albany NY). 13:19920–19941. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Liu YD, Wang YH, Ye YC, Zhao WL and Li L: Prognostic factors for mortality in patients with bullous pemphigoid: a meta-analysis. Arch Dermatol Res. 309:335–347. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Lai YC, Yew YW and Lambert WC: Bullous pemphigoid and its association with neurological diseases: A systematic review and meta-analysis. J Eur Acad Dermatology Venereol. 30:2007–2015. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Adam J, Pichler WJ and Yerly D: Delayed drug hypersensitivity: Models of T-cell stimulation. Br J Clin Pharmacol. 71:701–707. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Ruocco V, Satriano RA and Guerrera V: ‘Two-step’ pemphigus induction by ACE-inhibitors. Int J Dermatol. 31:33–36. 1992.PubMed/NCBI View Article : Google Scholar | |
|
Ruocco V and Sacerdoti G: Pemphigus and Bullous pemphigoid due to drugs. Int J Dermatol. 30:307–312. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Faina V, Sernicola A, Russo I, Michelotto A, Szathvary V, Frigo AC and Alaibac M: Programmed cell death-1 rs2227981 polymorphism in patients with autoimmune skin blistering disorders: A pilot study. Meta Gene. 26(100793)2020. | |
|
Stavropoulos PG, Soura E and Antoniou C: Drug-induced pemphigoid: A review of the literature. J Eur Acad Dermatology Venereol. 28:1133–1140. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Lo Schiavo A, Ruocco E, Brancaccio G, Caccavale S, Ruocco V and Wolf R: Bullous pemphigoid: Etiology, pathogenesis, and inducing factors: Facts and controversies. Clin Dermatol. 31:391–399. 2013.PubMed/NCBI View Article : Google Scholar | |
|
Drago F, Nozza P, Casazza S, Brusati C, Bandelloni R and Rebora A: Human herpesviruses in bullous pemphigoid lesions. Br J Dermatol. 152:375–376. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Iriki H, Adachi T, Matsuda H, Chinen K, Arakawa H, Yamagami J, Nishie W and Yokouchi M: Case of dipeptidyl peptidase 4 inhibitor-associated bullous pemphigoid that developed after a scabies infestation. J Dermatol. 47:e258–e260. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Mai Y, Nishie W, Sato K, Hotta M, Izumi K, Ito K, Hosokawa K and Shimizu H: Bullous pemphigoid triggered by thermal burn under medication with a dipeptidyl peptidase-IV inhibitor: A case report and review of the literature. Front Immunol. 9(542)2018.PubMed/NCBI View Article : Google Scholar | |
|
Vassileva S: Drug-induced pemphigoid: Bullous and cicatricial. Clin Dermatol. 16:379–387. 1998.PubMed/NCBI View Article : Google Scholar | |
|
Dănescu S, Chiorean R, Macovei V, Sitaru C and Baican A: Role of physical factors in the pathogenesis of bullous pemphigoid: Case report series and a comprehensive review of the published work. J Dermatol. 43:134–140. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Caca-Biljanovska N, Arsovska-Bezhoska I and V'lckova-Laskoska M: PUVA-induced bullous pemphigoid in psoriasis. Acta Dermatovenerol Croat. 24:214–217. 2016.PubMed/NCBI | |
|
Perl S, Rappersberger K, Födinger D, Anegg B, Hönigsmann H and Ortel B: Bullous pemphigoid induced by PUVA therapy. Dermatology. 193:245–247. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Preesman AH, Toonstra J, Van der Putte SC, De Geer DB, Van Weelden H and Van Vloten WA: UV-B-induced bullous pemphigoid restricted to mycosis fungoides plaques. Clin Exp Dermatol. 15:363–366. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Korekawa A, Kaneko T, Nakajima K, Rokunohe D, Akasaka E, Nakano H, Sawamura D, Fukui T, Takiyoshi N, Kitamura H and Harada K: Mycosis fungoides bullosa associated with bullous pemphigoid. Int J Dermatol. 54:e366–e368. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Mitsuhashi Y, Nakano H, Murai T, Ohta T, Sawamura D, Hanada K and Hashimoto I: Bullous pemphigoid sera induce bullous-pemphigoid-like lesions in neonatal mice pretreated with a limited dose of ultraviolet B irradiation. Dermatology. 189 (Suppl 1):S76–S81. 1994.PubMed/NCBI View Article : Google Scholar | |
|
Hall RP III, Murray JC, McCord MM, Rico MJ and Streilein RD: Rabbits Immunized with a Peptide Encoded for by the 230-kD bullous pemphigoid antigen cDNA develop an enhanced inflammatory response to UVB irradiation: A potential animal model for bullous pemphigoid. J Invest Dermatol. 101:9–14. 1993.PubMed/NCBI View Article : Google Scholar | |
|
Ho YH, Hu HY, Chang YT, Li CP and Wu CY: Psoriasis is associated with increased risk of bullous pemphigoid: A nationwide population-based cohort study in Taiwan. J Dermatol. 46:604–609. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Barnadas MA, Gilaberte M, Pujol R, Agustí M, Gelpí C and Alomar A: Bullous pemphigoid in a patient with psoriasis during the course of PUVA therapy: Study by ELISA test. Int J Dermatol. 45:1089–1092. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Wilczek A and Sticherling M: Concomitant psoriasis and bullous pemphigoid: Coincidence or pathogenic relationship? Int J Dermatol. 45:1353–1357. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Danno K, Takigawa M and Horio T: Alterations in lectin binding to the epidermis following treatment with 8-methoxypsoralen plus long-wave ultraviolet radiation. J Invest Dermatol. 82:176–179. 1984.PubMed/NCBI View Article : Google Scholar | |
|
George PM: Bullous pemphigoid possibly induced by psoralen plus ultraviolet a therapy. Photodermatol Photoimmunol Photomed. 11:185–187. 1996.PubMed/NCBI View Article : Google Scholar | |
|
Yesudian PD, Dobson CM, Ahmad R and Azurdia RM: Trauma-induced bullous pemphigoid around venous access site in a haemodialysis patient. Clin Exp Dermatol. 27:70–72. 2002.PubMed/NCBI View Article : Google Scholar | |
|
Neville JA and Yosipovitch G: Flare of bullous pemphigoid in surgically treated skin. Cutis. 75:169–170. 2005.PubMed/NCBI | |
|
Taghipour K, Chi CC, Vincent A, Groves RW, Venning V and Wojnarowska F: The association of bullous pemphigoid with cerebrovascular disease and dementia: A case-control study. Arch Dermatol. 146:1251–1254. 2010.PubMed/NCBI View Article : Google Scholar | |
|
Langan SM, Groves RW and West J: The relationship between neurological disease and bullous pemphigoid: A population-based case-control study. J Invest Dermatol. 131:631–636. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Brick KE, Weaver CH, Savica R, Lohse CM, Pittelkow MR, Boeve BF, Gibson LE, Camilleri MJ and Wieland CN: A population-based study of the association between bullous pemphigoid and neurologic disorders. J Am Acad Dermatol. 71:1191–1197. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Gambichler T, Segert H, Höxtermann S, Schmitz L, Altmeyer P and Teegen B: Neurological disorders in patients with bullous pemphigoid: clinical and experimental investigations. J Eur Acad Dermatology Venereol. 29:1758–1762. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kibsgaard L, Bay B, Deleuran M and Vestergaard C: A retrospective consecutive case-series study on the effect of systemic treatment, length of admission time, and co-morbidities in 98 bullous pemphigoid patients admitted to a tertiary centre. Acta Derm Venereol. 95:307–311. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Försti AK, Jokelainen J, Ansakorpi H, Seppänen A, Majamaa K, Timonen M and Tasanen K: Psychiatric and neurological disorders are associated with bullous pemphigoid-a nationwide finnish care register study. Sci Rep. 6(37125)2016.PubMed/NCBI View Article : Google Scholar | |
|
Khosravani S, Handjani F, Alimohammadi R and Saki N: Frequency of neurological disorders in bullous pemphigoid patients: A cross-sectional study. Int Sch Res Notices. 2017(6053267)2017.PubMed/NCBI View Article : Google Scholar | |
|
Ravn AH, Thyssen JP and Egeberg A: Skin disorders in Parkinson's disease: Potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 10:87–92. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Kalińska-Bienias A, Kowalczyk E, Jagielski P, Bienias P, Kowalewski C and Wozniak K: The association between neurological diseases, malignancies and cardiovascular comorbidities among patients with bullous pemphigoid: Case-control study in a specialized Polish center. Adv Clin Exp Med. 28:637–642. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Langan SM, Hubbard R, Fleming K and West J: A population-based study of acute medical conditions associated with bullous pemphigoid. Br J Dermatol. 161:1149–1152. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Heelan K, Mahar AL, Walsh S and Shear NH: Pemphigus and associated comorbidities: A cross-sectional study. Clin Exp Dermatol. 40:593–599. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Kremer N, Zeeli T, Sprecher E and Geller S: Failure of initial disease control in bullous pemphigoid: A retrospective study of hospitalized patients in a single tertiary center. Int J Dermatol. 56:1010–1016. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Hsu DY, Brieva J, Nardone B, West D and Silverberg JI: Association of pemphigus and systemic corticosteroid use with comorbid health disorders: A case-control study. Dermatol Online J. 23(13030/qt1vk2m30m)2017.PubMed/NCBI | |
|
Ungprasert P, Wijarnpreecha K and Thongprayoon C: Risk of venous thromboembolism in patients with bullous pemphigoid: A systematic review and meta-analysis. Indian J Dermatol Venereol Leprol. 84:22–26. 2018.PubMed/NCBI View Article : Google Scholar | |
|
Venning VA and Wojnarowska F: The association of bullous pemphigoid and malignant disease: A case control study. Br J Dermatol. 123:439–445. 1990.PubMed/NCBI View Article : Google Scholar | |
|
Bastuji-Garin S, Joly P, Lemordant P, Sparsa A, Bedane C, Delaporte E, Roujeau JC, Bernard P, Guillaume JC, Ingen-Housz-Oro S, et al: Risk factors for bullous pemphigoid in the elderly: A prospective case-control study. J Invest Dermatol. 131:637–643. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Schulze F, Neumann K, Recke A, Zillikens D, Linder R and Schmidt E: Malignancies in Pemphigus and Pemphigoid Diseases. J Invest Dermatol. 135:1445–1447. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Balestri R, Magnano M, La Placa M, Patrizi A, Angileri L, Tengattini V and Bardazzi F: Malignancies in bullous pemphigoid: A controversial association. J Dermatol. 43:125–133. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Callen JP: Internal disorders associated with bullous disease of the skin. A critical review. J Am Acad Dermatol. 3:107–119. 1980.PubMed/NCBI View Article : Google Scholar | |
|
Dahl MV: Bullous pemphigoid: Associated diseases. Clin Dermatol. 5:64–70. 1987.PubMed/NCBI View Article : Google Scholar | |
|
Chen YJ, Wu CY, Lin MW, Chen TJ, Liao KK, Chen YC, Hwang CY, Chu SY, Chen CC, Lee DD, et al: Comorbidity profiles among patients with bullous pemphigoid: A nationwide population-based study. Br J Dermatol. 165:593–599. 2011.PubMed/NCBI View Article : Google Scholar | |
|
Ljubojevic S and Lipozenčić J: Autoimmune bullous diseases associations. Clin Dermatol. 30:17–33. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Akarsu S, Özbağçivan Ö, Dolaş N and Aktan Ş: Possible triggering factors and comorbidities in newly diagnosed autoimmune bullous diseases. Turkish J Med Sci. 47:832–840. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Dainichi T and Kabashima K: Interaction of psoriasis and bullous diseases. Front Med. 5(222)2018.PubMed/NCBI View Article : Google Scholar | |
|
Harper EG, Guo C, Rizzo H, Lillis JV, Kurtz SE, Skorcheva I, Purdy D, Fitch E, Iordanov M and Blauvelt A: Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: Implications for psoriasis pathogenesis. J Invest Dermatol. 129:2175–2183. 2009.PubMed/NCBI View Article : Google Scholar | |
|
Watad A, Bragazzi NL, Adawi M, Amital H, Toubi E, Porat BS and Shoenfeld Y: Autoimmunity in the elderly: Insights from basic science and clinics-a mini-review. Gerontology. 63:515–523. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Lee YI, Choi S, Roh WS, Lee JH and Kim TG: Cellular senescence and inflammaging in the skin microenvironment. Int J Mol Sci. 22(3849)2021.PubMed/NCBI View Article : Google Scholar | |
|
Scott MM and Liang SY: Infections in older adults. Emerg Med Clin North Am. 39:379–394. 2021.PubMed/NCBI View Article : Google Scholar | |
|
Ganceviciene R, Liakou AI, Theodoridis A, Makrantonaki E and Zouboulis CC: Skin anti-aging strategies. Dermatoendocrinol. 4:308–319. 2012.PubMed/NCBI View Article : Google Scholar | |
|
Raine-Fenning NJ, Brincat MP and Muscat-Baron Y: Skin aging and menopause: Implication for treatment. Am J Clin Dermatol. 4:371–378. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Farage MA, Miller KW, Elsner P and Maibach HI: Intrinsic and extrinsic factors in skin ageing: A review. Int J Cosmet Sci. 30:87–95. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Chen Y and Lyga J: Brain-skin connection: Stress, inflammation and skin aging. Inflamm Allergy Drug Targets. 13:177–190. 2014.PubMed/NCBI View Article : Google Scholar | |
|
Schikowski T and Hüls A: Air pollution and skin aging. Curr Environ Health Rep. 7:58–64. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Nakyai W, Saraphanchotiwitthaya A, Viennet C, Humbert P and Viyoch J: An in vitro model for fibroblast photoaging comparing single and repeated UVA irradiations. Photochem Photobiol. 93:1462–1471. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Bhatia E, Kumari D, Sharma S, Ahamad N and Banerjee R: Nanoparticle platforms for dermal antiaging technologies: Insights in cellular and molecular mechanisms. Wiley Interdiscip Rev Nanomed Nanobiotechnol: Aug 22, 2021 (Epub ahead of print). | |
|
Xi YP, Nette EG, King DW and Rosen M: Age-related changes in normal human basement membrane. Mech Ageing Dev. 19:315–324. 1982.PubMed/NCBI View Article : Google Scholar | |
|
Bonté F, Girard D, Archambault JC and Desmoulière A: Skin changes during ageing. Subcell Biochem. 91:249–280. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Waller JM and Maibach HI: Age and skin structure and function, a quantitative approach (I): Blood flow, pH, thickness, and ultrasound echogenicity. Ski Res Technol. 11:221–235. 2005.PubMed/NCBI View Article : Google Scholar | |
|
Wilhelm KP, Cua AB and Maibach HI: Skin aging. Effect on transepidermal water loss, stratum corneum hydration, skin surface pH, and casual sebum content. Arch Dermatol. 127:1806–1809. 1991.PubMed/NCBI View Article : Google Scholar | |
|
Gilchrest BA, Blog FB and Szabo G: Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol. 73:141–143. 1979.PubMed/NCBI View Article : Google Scholar | |
|
Trivisonno A, Rossi A, Monti M, Di Nunno D, Desouches C, Cannistra C and Toietta G: Facial skin rejuvenation by autologous dermal microfat transfer in photoaged patients: Clinical evaluation and skin surface digital profilometry analysis. J Plast Reconstr Aesthetic Surg. 70:1118–1128. 2017.PubMed/NCBI View Article : Google Scholar | |
|
Buranasirin P, Pongpirul K and Meephansan J: Development of a global subjective skin aging assessment score from the perspective of dermatologists. BMC Res Notes. 12(364)2019.PubMed/NCBI View Article : Google Scholar | |
|
Mine S, Fortunel NO, Pageon H and Asselineau D: Aging alters functionally human dermal papillary fibroblasts but not reticular fibroblasts: A new view of skin morphogenesis and aging. PLoS One. 3(e4066)2008.PubMed/NCBI View Article : Google Scholar | |
|
Hall BM, Balan V, Gleiberman AS, Strom E, Krasnov P, Virtuoso LP, Rydkina E, Vujcic S, Balan K, Gitlin I, et al: Aging of mice is associated with p16(Ink4a)- and β-galactosidase-positive macrophage accumulation that can be induced in young mice by senescent cells. Aging (Albany NY). 8:1294–1315. 2016.PubMed/NCBI View Article : Google Scholar | |
|
Ressler S, Bartkova J, Niederegger H, Bartek J, Scharffetter-Kochanek K, Jansen-Durr P and Wlaschek M: p16 INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell. 5:379–389. 2006.PubMed/NCBI View Article : Google Scholar | |
|
Pereira BI, Devine OP, Vukmanovic-Stejic M, Chambers ES, Subramanian P, Patel N, Virasami A, Sebire NJ, Kinsler V, Valdovinos A, et al: Senescent cells evade immune clearance via HLA-E-mediated NK and CD8+ T cell inhibition. Nat Commun. 10(2387)2019.PubMed/NCBI View Article : Google Scholar | |
|
Waldera Lupa DM, Kalfalah F, Safferling K, Boukamp P, Poschmann G, Volpi E, Götz-Rösch C, Bernerd F, Haag L, Huebenthal U, et al: Characterization of skin aging-associated secreted proteins (SAASP) produced by dermal fibroblasts isolated from intrinsically aged human skin. J Invest Dermatol. 135:1954–1968. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Fligiel SE, Varani J, Datta SC, Kang S, Fisher GJ and Voorhees JJ: Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol. 120:842–848. 2003.PubMed/NCBI View Article : Google Scholar | |
|
Le Page A, Khalil A, Vermette P, Frost EH, Larbi A, Witkowski JM and Fulop T: The role of elastin-derived peptides in human physiology and diseases. Matrix Biol. 84:81–96. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang Z, Zhu H, Zheng Y, Zhang L, Wang X, Luo Z, Tang J, Lin L, Du Z and Dong C: The effects and mechanism of collagen peptide and elastin peptide on skin aging induced by D-galactose combined with ultraviolet radiation. J Photochem Photobiol B. 210(111964)2020.PubMed/NCBI View Article : Google Scholar | |
|
Farage MA, Miller KW, Elsner P and Maibach HI: Functional and physiological characteristics of the aging skin. Aging Clin Exp Res. 20:195–200. 2008.PubMed/NCBI View Article : Google Scholar | |
|
Zhang LJ, Chen SX, Guerrero-Juarez CF, Li F, Tong Y, Liang Y, Liggins M, Chen X, Chen H, Li M, et al: Age-related loss of innate immune antimicrobial function of dermal fat is mediated by transforming growth factor beta. Immunity. 50:121–136.e5. 2019.PubMed/NCBI View Article : Google Scholar | |
|
Zhang L, Guerrero-Juarez CF, Hata T, Bapat SP, Ramos R, Plikus MV and Gallo RL: Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science. 347:67–71. 2015.PubMed/NCBI View Article : Google Scholar | |
|
Chambers ES and Vukmanovic-Stejic M: Skin barrier immunity and ageing. Immunology. 160:116–125. 2020.PubMed/NCBI View Article : Google Scholar | |
|
Guimarães GR, Almeida PP, de Oliveira Santos L, Rodrigues LP, de Carvalho JL and Boroni M: Hallmarks of aging in macrophages: Consequences to skin inflammaging. Cells. 10(1323)2021.PubMed/NCBI View Article : Google Scholar | |
|
Low E, Alimohammadiha G, Smith LA, Costello LF, Przyborski SA, von Zglinicki T and Miwa S: How good is the evidence that cellular senescence causes skin ageing? Ageing Res Rev. 71(101456)2021.PubMed/NCBI View Article : Google Scholar | |
|
Stevens NE, Cowin AJ and Kopecki Z: Skin barrier and autoimmunity-mechanisms and novel therapeutic approaches for autoimmune blistering diseases of the skin. Front Immunol. 10(1089)2019.PubMed/NCBI View Article : Google Scholar | |
|
Liu Y, Li L and Xia Y: BP180 is critical in the autoimmunity of bullous pemphigoid. Front Immunol. 8(1752)2017.PubMed/NCBI View Article : Google Scholar | |
|
Hooten J, Hall RP III and Cardones A: Updates on the management of autoimmune blistering diseases. Skin Therapy Lett. 19:1–6. 2014.PubMed/NCBI |
